Article

Eyeonics releases enhanced lens design

Aliso Viejo, CA—Eyeonics Inc. said it has enhanced its crystalens design and eliminated the need for postoperative cycloplegia in its newly released crystalens SE system.

Aliso Viejo, CA-Eyeonics Inc. said it has enhanced its crystalens design and eliminated the need for postoperative cycloplegia in its newly released crystalens SE system.

The "system," which the company announced last month, has three facets: the company extended the square edge all the way around the crystalens to help maintain the capsular bag; said it was no longer necessary to paralyze the ciliary muscles postoperatively; and announced a new delivery system for the lens.

The company said the lens was validated for use with the STAAR Indigo Injector System, which allows the lens to be inserted via a smaller, sub-3-mm incision without directly handling it.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
© 2025 MJH Life Sciences

All rights reserved.